Lloyd Advisory Services’s Amicus Therapeutics FOLD Stock Holding History

Lloyd Advisory Services’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,327	Closed	-$164K	–	762
2026 Q1	$164K	Buy	+11,327	New	+$162K	0.05%	164

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Lloyd Advisory Services's FOLD Position: Q2 2026 in Review

Lloyd Advisory Services sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 11,327 shares — an estimated $164K sold.

Lloyd Advisory Services first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $164K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Lloyd Advisory Services reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Lloyd Advisory Services sold 11,327 Amicus Therapeutics shares in Q2 2026, an estimated $164K.
Lloyd Advisory Services first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
Lloyd Advisory Services's Amicus Therapeutics position peaked at $164K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Lloyd Advisory Services's 13F filing for Q2 2026, filed 7 Aug 2026.